{"name": "VisionCare Ophthalmic Technologies",
 "permalink": "visioncare-ophthalmic-technologies",
 "crunchbase_url": "http://www.crunchbase.com/company/visioncare-ophthalmic-technologies",
 "homepage_url": "http://www.visioncareinc.net",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "customercare@visioncareinc.net",
 "phone_number": "408.872.9393",
 "description": "",
 "created_at": "Wed Jan 12 03:00:55 UTC 2011",
 "updated_at": "Tue Apr 09 04:16:15 UTC 2013",
 "overview": "\u003Cp\u003EVisionCare Ophthalmic Technologies, Inc., a Saratoga, CA-based developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD).\u003C/p\u003E\n\n\u003Cp\u003EVisionCare Ophthalmic Technologies (VisionCare) is a privately held specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.\u003C/p\u003E\n\n\u003Cp\u003EOur lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration (AMD) \u2013 End-Stage AMD. End-Stage AMD is the leading cause of blindness in older Americans.\u003C/p\u003E\n\n\u003Cp\u003EThe telescope implant is integral to the CentraSight\u2122 treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care.\u003C/p\u003E\n\n\u003Cp\u003EOur goal is to help patients reconnect to the things in life they love to see and do. To help achieve this, we will establish a high level of collaboration with our healthcare provider customers through a broad range of direct support programs and services.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       60],
      "assets/images/resized/0011/6920/116920v1-max-150x150.png"],
     [[250,
       100],
      "assets/images/resized/0011/6920/116920v1-max-250x250.png"],
     [[286,
       115],
      "assets/images/resized/0011/6920/116920v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Allen",
      "last_name": "W. Hill",
      "permalink": "allen-w-hill",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$35M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "http://www.finsmes.com/2011/01/visioncare-ophthalmic-technologies.html",
    "source_description": "VisionCare Ophthalmic Technologies Closes $31M Series E Financing",
    "raised_amount": 31000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Giza Venture Capital",
         "permalink": "giza-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               67],
              "assets/images/resized/0001/3882/13882v5-max-150x150.jpg"],
             [[231,
               104],
              "assets/images/resized/0001/3882/13882v5-max-250x250.jpg"],
             [[231,
               104],
              "assets/images/resized/0001/3882/13882v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BSI SA",
         "permalink": "bsi-sa",
         "image":
          {"available_sizes":
            [[[80,
               40],
              "assets/images/resized/0010/0602/100602v1-max-150x150.jpg"],
             [[80,
               40],
              "assets/images/resized/0010/0602/100602v1-max-250x250.jpg"],
             [[80,
               40],
              "assets/images/resized/0010/0602/100602v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pitango Venture Capital",
         "permalink": "pitango-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0001/8978/18978v1-max-150x150.png"],
             [[206,
               73],
              "assets/images/resized/0001/8978/18978v1-max-250x250.png"],
             [[206,
               73],
              "assets/images/resized/0001/8978/18978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Three Arch Partners",
         "permalink": "three-arch-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0003/0743/30743v1-max-150x150.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-250x250.png"],
             [[230,
               80],
              "assets/images/resized/0003/0743/30743v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ONSET Ventures",
         "permalink": "onset-ventures",
         "image":
          {"available_sizes":
            [[[150,
               66],
              "assets/images/resized/0003/0361/30361v2-max-150x150.png"],
             [[209,
               92],
              "assets/images/resized/0003/0361/30361v2-max-250x250.png"],
             [[209,
               92],
              "assets/images/resized/0003/0361/30361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "e",
    "source_url": "http://www.visioncareinc.net/press_releases/pr_1327113425",
    "source_description": "VisionCare Announces Close of Series E Expansion Financing and Board Changes",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 1,
    "funded_day": 23,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "14395 Saratoga Ave",
    "address2": "Suite 150",
    "zip_code": "95070",
    "city": "Saratoga",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}